Lisa K. Brents

Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity

Lisa K. Brents, Emily E. Reichard, Sarah M. Zimmerman et al. · PLoS ONE · 2011 · 210 citations · Full text

Cytochrome P450-Mediated Oxidative Metabolism of Abused Synthetic Cannabinoids Found in K2/Spice: Identification of Novel Cannabinoid Receptor Ligands

Krishna C. Chimalakonda, Kathryn A. Seely, Stacie M. Bratton et al. · Drug Metabolism and Disposition · 2012 · 183 citations · Full text

Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity

Lisa K. Brents, Anna Gallus‐Zawada, Anna Radomińska‐Pandya et al. · Biochemical Pharmacology · 2012 · 142 citations · Full text

Cannabis Use, Partial Agonist Activity, Biochemistry +11

AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies

Kathryn A. Seely, Lisa K. Brents, Lirit N. Franks et al. · Neuropharmacology · 2012 · 100 citations

Cannabis Use, Molecular Pharmacology, Functional Selectivity +14

Marijuana, the Endocannabinoid System and the Female Reproductive System.

Lisa K. Brents · PubMed · 2016 · 96 citations · Full text

Chronic Marijuana Use, Hormonal Contraceptive, Fertility +21